Dr. Michael Paul Link MD

Awards

•  2004 Annual Memorial Lectureship, Pediatric Cancer Research Foundation 
• Washington University School of Medicine 2000 Ben Abelson Memorial Visiting Professor 
•  1974 Alpha Omega Alpha, Alpha Omega Alpha 
•  2013 21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD An 
• Brent Eley Visiting Professor in Pediatric Oncology, 2009 University of Colorado Cancer Center and the Childrens Hospital, Denve 
•   Phi Beta Kappa 
• The Royal Academy of Paediatrics and Child Health (June) 2013 Honorary Fellow 

Treatments

• Stem Cell Transplant

Fellowships

• Children's Hospital Boston, Boston, MA    1979
• Dana-Farber Cancer Institute, Boston, MA    1979
• Dana-Farber Cancer Institute MA    1979
• Children's Hospital Boston MA    1979

Publications

• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAdolescent and Young Adult Oncology, Version 2.20142014
• PEDIATRIC BLOOD & CANCERRelapse after treatment of pediatric hodgkin lymphoma2013
• NEW ENGLAND JOURL OF MEDICINEThe Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine2012
• BLOOD CANCER JOURLExtremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia2012
• Jourl of the tiol Comprehensive Cancer NetworkAdolescent and young adult oncology. Clinical practice guidelines in oncology.2012
• PEDIATRIC BLOOD & CANCERALK+ aplastic large cell lymphoma exhibits phosphatidylinositol-3 kise2012
• JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONAssociation Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy2012
• JOURL OF CLINICAL ONCOLOGYChemotherapy Drug Shortages in the United States: Genesis and Potential Solutions2012
• PEDIATRIC NEUROSURGERYComplete Ocular Paresis in a Child with Posterior Fossa Syndrome2012
• JOURL OF CLINICAL ONCOLOGYSecond Malignt Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low2010
• JOURL OF CLINICAL ONCOLOGYThe Impact of the Privacy Rule on Cancer Research2009
• PEDIATRIC BLOOD & CANCERNon-aplastic peripheral T-cell lymphoma in childhood and adolescence2008
• APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGYNodular lymphocyte-predomint Hodgkin lymphoma presenting as fulmint hepatic failure in a pediatric2008
• JOURL OF CLINICAL ONCOLOGYOsteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival2008
• PEDIATRIC BLOOD & CANCERTreatment of metastatuc Ewing Sarcoma2007
• JOURL OF CLINICAL ONCOLOGYFil results of a prospective clinical trial with VAMP2007
• BLOODTherapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive2007
• BIOELECTROMAGNETICSMagnetic field exposure and prognostic factors in childhood leukemia2007
• BRITISH JOURL OF CANCERMagnetic field exposure and long-term survival among children with leukaemia2006
• JOURL OF CLINICAL ONCOLOGYIntensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis2006
• PEDIATRIC AND DEVELOPMENTAL PATHOLOGYReview of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group2005
• JOURL OF CLINICAL ONCOLOGYOsteosarcoma: A randomized, prospective trial of the addition of ifosfamide and2005
• PEDIATRIC BLOOD & CANCEREpstein-Barr virus-associated peripheral T-cell lymphoma2005
• JOURL OF CLINICAL ONCOLOGYHigh-dose therapy and autologous hematopoietic stem2004
• JOURL OF CLINICAL ONCOLOGYRisk-adapted, combined-modality therapy with VAMP2004
• CLINICAL CANCER RESEARCHCyclophosphamide dose intensification during induction therapy for intermediate2004
• JOURL OF CLINICAL ONCOLOGYTreatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone2004
• CANCERHigh-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma2004
• Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendrictiol Institutes of Health State-of-the-Science Conference Statement: Symptom Magement in Cancer0
• JOURL OF CLINICAL ONCOLOGYPrognostic factors for children with Hodgkin's disease treated with combined-modality therapy2003
• JOURL OF CLINICAL ONCOLOGYPresurgical chemotherapy compared with immediate surgery2003
• NEW ENGLAND JOURL OF MEDICINEAddition of ifosfamide and etoposide to standard chemotherapy2003
• JOURL OF CLINICAL ONCOLOGYPrognostic factors and clinical outcomes2003
• JOURL OF CLINICAL ONCOLOGYChildren from ethnic minorities have benefited equally2002
• CA: a cancer jourl for clinicianstiol action plan for childhood cancer: report of the tiol summit meetings on childhood cancer.2002
• PEDIATRIC CLINICS OF NORTH AMERICAAssessment of lymphadenopathy in children2002
• STATISTICS IN MEDICINEMinimax two-stage-designs with applications to tissue banking case-control studies2002
• JOURL OF CLINICAL ONCOLOGYTreatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose2002
• JOURL OF CLINICAL ONCOLOGYVAMP and low-dose, involved-field radiation for children and adolescents with favorable2002
• LEUKEMIABone marrow stroma-supported culture of T2002
• CLINICAL CANCER RESEARCHDose escalation and pharmacokinetics of pegylated liposomal doxorubicin2002
• JOURL OF CLINICAL ONCOLOGYPhase II/III trial of etoposide and high-dose ifosfamide2002
• MEDICAL AND PEDIATRIC ONCOLOGYEfficacy of ifosfamide2001
• JOURL OF CLINICAL ONCOLOGYWhich patients with microscopic disease2001
• Semirs in pediatric surgeryControversies in the magement of paratesticular rhabdomyosarcoma2001
• JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGYPresurgical window of carboplatin and surgery and multidrug chemotherapy2001
• Arndt, C. A., Doldson, S. S., Anderson, J. R., Andrassy, R. J., LaurieWhat constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?2001
• JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGYThyroid carcinoma after successful treatment of osteosarcoma: A report of three patients2001
• JOURL OF CLINICAL ONCOLOGYAttitudes and practices among pediatric oncologists regarding end-of-life care2001
• BLOODNew recurring cytogenetic abnormalities2000
• JOURL OF CLINICAL ONCOLOGYBenefit of intensified therapy for patients with local or regiol embryol rhabdomyosarcoma2000
• LEUKEMIAEffects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia2000
• Hutchison, R. E., Finch, C., Kepner, J., Fuller, C., Bowman, P., Link,Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons2000
• LEUKEMIASignificance of commonly used prognostic factors differs1999
• LEUKEMIAIntensive high-dose asparagise consolidation improves survival for pediatric patients with T cell1999
• JOURL OF CLINICAL ONCOLOGYTreatment of localized primary non-Hodgkin's lymphoma of bone in children1999
• JOURL OF CLINICAL ONCOLOGYChildhood acute lymphoblastic leukemia with the MLL-ENL fusion1999
• LEUKEMIAAcute lymphoblastic leukemia with the (8;14)(q24;q32) translocation1999
• JOURL OF CLINICAL ONCOLOGYTreatment of metastatic osteosarcoma at diagnosis: A pediatric oncology group study1998
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA multidiscipliry study investigating radiotherapy in Ewing's sarcoma: End results of POG #83461998
• JOURL OF CLINICAL ONCOLOGYRandomized trial of r1998
• BLOODE2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome1998
• MEDICAL AND PEDIATRIC ONCOLOGYFractioted cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside1997
• NEW ENGLAND JOURL OF MEDICINETreatment of children and young adults with early-stage non-Hodgkin's lymphoma1997
• LEUKEMIALack of ETV6 (TEL) gene rearrangements or p16(INK4A)1997
• JOURL OF CLINICAL ONCOLOGYAltered expression of p531997
• JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGYA feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the1997
• CANCER RESEARCHFrequent and selective methylation of p15 and deletion of both p15 and p16 in T1997
• BLOODCase-control study suggests a favorable impact of TEL rearrangement in patients with B1997
• ANLS OF ONCOLOGYUse of an anti-ALK antibody in the characterization of aplastic large-cell lymphoma of childhood1997
• Oncology (Williston Park, N.Y.)NCCN pediatric osteosarcoma practice guidelines. The tiol Comprehensive Cancer Network.1996
• JOURL OF CLINICAL ONCOLOGYImproved survival for children with B-cell acute lymphoblastic leukemia1996
• BLOODHigh incidence of potential p53 ictivation1996
• JOURL OF CLINICAL ONCOLOGYUniform approach to risk classification1996
• EXPERIMENTAL HEMATOLOGYSTAGE-SPECIFIC AND LINEAGE1995
• JOURL OF CLINICAL ONCOLOGYB-CELL LINEAGE CONFERS A FAVORABLE OUTCOME AMONG CHILDREN AND ADOLESCENTS WITH LARGE1995
• MEDICAL AND PEDIATRIC ONCOLOGYSAFETY AND EFFICACY OF L-LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE FOR OSTEOSARCOMA1995
• MEDICAL AND PEDIATRIC ONCOLOGYTREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE IN PEDIATRIC1995
• JOURL OF CLINICAL ONCOLOGYABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY1994
• JOURL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICSHYPNOSIS IN THE PREVENTION OF CHEMOTHERAPY-RELATED USEA AND VOMITING IN CHILDREN1994
• BLOODFREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF HRX REARRANGEMENTS IN INFANT ACUTE LYMPHOBLASTIC1994
• LEUKEMIASIMULTANEOUS EXPRESSION OF RBTN-2 AND BCR1994
• CANCER GENETICS AND CYTOGENETICSPRESENTING CHARACTERISTICS OF TRISOMY1994
• HUMAN PATHOLOGYMIC2 ALYSIS IN PEDIATRIC LYMPHOMAS AND LEUKEMIAS1994
• HUMAN PATHOLOGYEWINGS-SARCOMA - ROUTINE DIAGNOSTIC UTILIZATION OF MIC2 ALYSIS - A PEDIATRIC-ONCOLOGY-GROUP1994
• MEDICAL AND PEDIATRIC ONCOLOGYSECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA1994
• Cleary, S. F., Link, M. P., Doldson, S. S.HODGKINS-DISEASE IN THE VERY YOUNG1994
• HISTOPATHOLOGYIMMUNOCYTOCHEMICAL STUDY OF 12E7 IN SMALL ROUND-CELL TUMORS OF CHILDHOOD1993
• AMERICAN JOURL OF PATHOLOGYDETECTION OF THE (11 22)(Q24 Q12) TRANSLOCATION OF EWINGS1993
• BLOODHRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES1993
• JOURL OF CLINICAL ONCOLOGYACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE1993
• Link, M. P., Stevens, J., Friend, S. H., Israel, M. A., Knudson, A. G.LABORATORY CLINICAL INTERFACE1993
• BLOODCLINICAL-FEATURES AND OUTCOME OF T1993
• BLOODA SERINE PROLINE-RICH PROTEIN IS FUSED TO HRX IN T(4-11) ACUTE LEUKEMIAS1993
• Cancer treatment and researchThe multi-institutiol osteosarcoma study: an update.1993
• MEDICAL AND PEDIATRIC ONCOLOGYLANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VE-CAVA SYNDROME - A CASE-REPORT1993
• Cancer treatment and researchOsteosarcoma in adolescents and young adults1993
• INVESTIGATIOL NEW DRUGSA STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE1992
• LEUKEMIACHILDHOOD MALIGNT NON-HODGKIN LYMPHOMAS OF UNCOMMON HISTOLOGY1992
• LEUKEMIAMORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC0

Experience & Accolades

• Member2010 - 2011President-Elect, American Society of Clinical Oncology
• Member2000 - 2010 Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine
• Director Center for Cancer and Blood Diseases, Lucile Packard
• Member2002 - 2010 Children's Hospital at Stanford
• Lydia J. Lee Professor 2003 - 2014 Pediatric Cancer, Stanford University
• Member2011 - 2012 President, American Society of Clinical Oncology

Dr. Michael Paul Link MD's Practice location